Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
Ramipril-tablet
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
  tablets-red  
  HOME >> PRODUCTS >> Generic Medicines >> Taj Generics >> Page 6 >> Ramipril tablet
 
  Ramipril tablet  

 

 


COMPOSITION :
Ramipril-1.25 Tablets
Each tablet contains……….Ramipril 1.25 mg

Ramipril-2.5 Tablets
Each tablet contains……….Ramipril 2.5 mg

Ramipril-5 Tablets
Each tablet contains……….Ramipril 5 mg
 

      For more information, please see Full Prescribing Information.

INDICATIONS

  • Reduction in risk of myocardial infarction, stroke and death from cardiovascular causes
  • Hypertension
  • Heart failure post myocardial infarction

DOSAGE AND ADMINISTRATION Reduction in risk of myocardial infarction, stroke and death from cardiovascular causes
Ramipril
should be given at an initial dose of 2.5 mg, once a day for 1 week, 5 mg, once a day for the next 3 weeks and then increased as tolerated, to a maintenance dose of 10 mg, once daily. If the patient is hypertensive or recently post myocardial infarction, it can be given as a divided dose.

Hypertension
The recommended initial dose of Ramipril is 2.5 mg once daily in patients not receiving a diuretic. Dosage should be adjusted according to the blood pressure response. The usual maintenance dosage range is 2.5 to 20 mg/day administered as a single dose or in two equally divided doses. If blood pressure is not controlled with ramipril alone, a diuretic can be added.

Heart failure post myocardial infarction
The recommended starting dose of Ramipril is 2.5 mg twice daily. A patient who becomes hypotensive at this dose may be switched to 1.25 mg twice daily, and after one week at the starting dose, patients should be titrated (if tolerated) toward a target dose of 5 mg twice daily, with dosage increases being about 3 weeks apart. After the initial dose of ramipril, the patient should be observed under medical supervision for at least two hours and until blood pressure has stabilized for at least an additional hour. If possible, the dose of any concomitant diuretic should be reduced which may diminish the likelihood of hypotension.

In patients who are currently being treated with a diuretic, symptomatic hypotension occasionally can occur following the initial dose of ramipril. To reduce the likelihood of hypotension, the diuretic should, if possible, be discontinued two to three days prior to beginning therapy with ramipril. Then, if blood pressure is not controlled with ramipril alone, diuretic therapy should be resumed. If the diuretic cannot be discontinued, an initial dose of 1.25 mg ramipril should be used to avoid excess hypotension.

Dosage in renal impairment
In patients with creatinine clearance less than 40 mL/min/1.73m 2 (serum creatinine approximately more than 2.5 mg/dl) doses only 25% of those normally used should be expected to induce full therapeutic levels of ramiprilat.

Hypertension
For patients with hypertension and renal impairment, the recommended initial dose is 1.25 mg ramipril once daily. Dosage may be titrated upward until blood pressure is controlled or to a maximum total daily dose of 5 mg.

Heart failure post myocardial infarction
For patients with heart failure and renal impairment, the recommended initial dose is 1.25 mg ramipril once daily. The dose may be increased to 1.25 mg twice daily and up to a maximum dose of 2.5 mg twice daily depending upon clinical response and tolerability.

CONTRAINDICATIONS
Hypersensitivity to ramipril or any other ACE inhibitor (e.g. a patient who has experienced angioedema during therapy with any other ACE inhibitor).  


PACKAGING INFORMATION :
Ramipril-1.25 ..............Strip of 10 tablets
Ramipril-2.5 ................Strip of 10 tablets
Ramipril-5 ...................Strip of 10 tablets

Wallpapers :     Ramipril tablet information
     CLICK ON PHOTO TO SEE LARGE.


 
product enquiry product quotation sample request order now
Product Enquiry Product Quotation Sample Request Order Now
       
       
   Information about Generic Medicines   career
   Information about Manufacturing   career
 

 Ramipril tablet

Ramipril 10mg tablet
Pharmaceuticals Generics
  (Triprolidine, Pseudoephedrine) tablets, syrup  
  (Barium sulphate) suspension  
  Water for injections  
  Trimetazidine Dihydrochloride tablet  
  Tamsulosin Hydrochloride 0.4 mg Capsule  
  Ramipril tablet  
  Betahistine hydrochloride
Tablet
 
  Clopidogrel tablet  
  Fenofibrate Capsule  
  Lamotrigine 50mg / 100mg Tablets  
  Topiramate Tablets  
 

More..

 















































          
 Print page   Send by mail

 

 


 

 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`


















































 
 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement